Funding
← Back to your selection

Venrock

Activity from announced rounds

Activity in this selectionSeries C+

Venrock is the venture manager whose own Encoded portfolio identifies investor Bryan Roberts.

Recorded funding activity

Encoded develops neurological gene therapies. Other recorded companies include Gitar’s software-review agents and Adcendo’s targeted cancer medicines. Venrock Healthcare Capital Partners remains a separate manager identity.

Sources
Rounds participated in
3
Confirmed lead rounds
0
1 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$440M
3 disclosed · full round size, not this investor’s share

By stage

Series C+3

By primary sector

Biotech2
Healthtech1

By country

United States2
Denmark1

Rounds

3 in this selection
Suki

Suki develops AI software that helps clinicians document visits and healthcare technology vendors embed clinical assistance in their products.

$90MSeries E
Participant
Encoded Therapeutics Inc.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

$275MSeries F
Participant
Adcendo

Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.

$75MSeries C
Role not disclosed